(Q30357731)

English

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good R

scientific article

Statements

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good R (English)
0 references
0 references
0 references
0 references
Stefan S Bielack
Sigbjørn Smeland
Jeremy S Whelan
Zsuzsanna Pápai
Claudia Deffenbaugh
Rajaram Nagarajan
Bernadette Brennan
G Douglas Letson
Daniel Baumhoer
Mathias Werner
Kirsten Sundby Hall
Mikael Eriksson
Peter M Hoogerbrugge
Paula Schomberg
Henk van den Berg
Marleen Renard
Peter Reichardt
Trude Butterfass-Bahloul
Beatrice Seddon
Gabriele Calaminus
Maria Michelagnoli
Catharina Dhooge
Mark Bernstein
EURAMOS-1 investigators

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit